Sevoflurane attenuates ventilator‑induced lung injury by regulating c‑PLA2 expression

Yang,Yong; Wang,Wen‑Fa; Li,Yan‑Hua; Li,Li‑Sha; Guo,Xin; Liu,Rui

doi:10.3892/mmr.2018.9243

Sevoflurane attenuates ventilator‑induced lung injury by regulating c‑PLA2 expression

Authors:
- Yong Yang
- Wen‑Fa Wang
- Yan‑Hua Li
- Li‑Sha Li
- Xin Guo
- Rui Liu
View Affiliations

Affiliations: Experimental Center of Medical Function, Kunming Medical University, Kunming, Yunnan 650031, P.R. China, Department of Anesthesiology, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, Yunnan 675000, P.R. China, Department of Anesthesiology, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China
Published online on: July 3, 2018 https://doi.org/10.3892/mmr.2018.9243
Pages: 2923-2928

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the potential role of club cell secretory protein (CCSP), an endogenous modulator, in reducing pulmonary inflammation induced by sevoflurane following one‑lung ventilation (OLV). Healthy Japanese white rabbits were randomly assigned to six groups: Sham‑operated group (group S); respiratory management of OLV group (group O); OLV + sevoflurane treated group (group OF), club cells exfoliated + sham‑operated group (group NA), club cells exfoliated + OLV group (group NAO); and club cells exfoliated + OLV + sevoflurane treated group (group NAOF). At the end of the experimental observation, all animals in the different groups were sacrificed and lung injury was evaluated according to the lung wet/dry weight ratio and histological scoring system. Lung homogenates were harvested to detect the mRNA and protein expression of cytosolic phospholipase A2 (c‑PLA2) and CCSP. The content of arachidonic acid was measured using an ELISA. Following OLV treatment, c‑PLA2 expression was increased, CCSP expression was decreased and lung injury scores were significantly increased. Sevoflurane inhalation in the OLV‑treated group induced an upregulation of CCSP and a downregulation of c‑PLA2 expression. In the group NAO, in which the club cells were simultaneously exfoliated, OLV caused more severe lung damage and induced higher expression of c‑PLA2 compared with that in group O. However, sevoflurane inhalation reduced the extent of lung injury and the expression of c‑PLA2, even when the endogenous modulator of lung inflammation, CCSP, was exfoliated (group NAOF). These results indicated that OLV promoted lung inflammation through the CCSP and c‑PLA2 pathway. However, the results from the club cells exfoliated group indicated that the CCSP may not be involved in the protective effect exerted by sevoflurane inhalation.

View Figures

View References

1	Zeldin RA, Normandin D, Landtwing D and Peters RM: Postpneumonectomy pulmonary edema. J Thorac Cardiovasc Surg. 87:359–365. 1984.PubMed/NCBI
2	Della Rocca G and Coccia C: Acute lung injury in thoracic surgery. Curr Opin Anaesthesiol. 26:40–46. 2013. View Article : Google Scholar : PubMed/NCBI
3	Hegeman MA, Hennus MP, Heijnen CJ, Specht PA, Lachmann B, Jansen NJ, van Vught AJ and Cobelens PM: Ventilator-induced endothelial activation and inflammation in the lung and distal organs. Crit Care. 13:R1822009. View Article : Google Scholar : PubMed/NCBI
4	Kilpatrick B and Slinger P: Lung protective strategies in anaesthesia. Br J Anaesth. 105 Suppl 1:i108–i116. 2010. View Article : Google Scholar : PubMed/NCBI
5	Wolthuis EK, Vlaar AP, Choi G, Roelofs JJ, Juffermans NP and Schultz MJ: Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice. Crit Care. 13:R12009. View Article : Google Scholar : PubMed/NCBI
6	Andersson O, Nordlund-Möller L, Barnes HJ and Lund J: Heterologous expression of human uteroglobin/polychlorinated biphenyl-binding protein. Determination of ligand binding parameters and mechanism of phospholipase A2 inhibition in vitro. J Biol Chem. 269:19081–19087. 1994.PubMed/NCBI
7	Magrioti V and Kokotos G: Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. Expert Opin Ther Pat. 20:1–18. 2010. View Article : Google Scholar : PubMed/NCBI
8	Kitsiouli E, Nakos G and Lekka ME: Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta. 1792:941–953. 2009. View Article : Google Scholar : PubMed/NCBI
9	Leslie CC: Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2. Prostaglandins Leukot Essent Fatty Acids. 70:373–376. 2004. View Article : Google Scholar : PubMed/NCBI
10	Kapoor M, Clarkson AN, Sutherland BA and Appleton I: The role of antioxidants in models of inflammation: Emphasis on L-arginine and arachidonic acid metabolism. Inflammopharmacology. 12:505–519. 2005. View Article : Google Scholar : PubMed/NCBI
11	Samuelsson B: Arachidonic acid metabolism: Role in inflammation. Z Rheumatol. 50 Suppl 1:S3–S6. 1991.
12	Murakami M and Kudo I: Phospholipase A2. J Biochem. 131:285–292. 2002. View Article : Google Scholar : PubMed/NCBI
13	Reynolds SD and Malkinson AM: Clara cell: Progenitor for the bronchiolar epithelium. Int J Biochem Cell Biol. 42:1–4. 2010. View Article : Google Scholar : PubMed/NCBI
14	Harrod KS, Mounday AD, Stripp BR and Whitsett JA: Clara cell secretory protein decreases lung inflammation after acute virus infection. Am J Physiol. 275:L924–L930. 1998.PubMed/NCBI
15	Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ and Bernard A: Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J. 8:1647–1653. 1995. View Article : Google Scholar : PubMed/NCBI
16	Steurer M, Schläpfer M, Steurer M, Z'Graggen BR, Booy C, Reyes L, Spahn DR and Beck-Schimmer B: The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages. Clin Exp Immunol. 155:224–230. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kong HY, Zhu SM, Wang LQ, He Y, Xie HY and Zheng SS: Sevoflurane protects against acute kidney injury in a small-size liver transplantation model. Am J Nephrol. 32:347–55. 2010. View Article : Google Scholar : PubMed/NCBI
18	Liu R, Yang Y, Li Y, Li J, Ma Q, Zhao Y and Wang D: Effects of sevoflurane on pulmonary cytosolic phospholipase A₂ and clara cell secretory protein expressions in rabbits with one-lung ventilation-induced lung injury. Nan Fang Yi Ke Da Xue Xue Bao. 33:469–473. 2013.PubMed/NCBI
19	The Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health. NIH Publication 85–23. revised. 1996.
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Bauer P: Postpneumonectomy pulmonary oedema revisited. Eur Respir J. 15:629–630. 2000. View Article : Google Scholar : PubMed/NCBI
22	Kozian A, Schilling T, Röcken C, Breitling C, Hachenberg T and Hedenstierna G: Increased alveolar damage after mechanical ventilation in a porcine model of thoracic surgery. J Cardiothorac Vasc Anesth. 24:617–623. 2010. View Article : Google Scholar : PubMed/NCBI
23	Burke JE and Dennis EA: Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res. 50 Suppl:S237–S242. 2009. View Article : Google Scholar : PubMed/NCBI
24	Burke JE and Dennis EA: Phospholipase A2 biochemistry. Cardiovasc Drugs Ther. 23:49–59. 2009. View Article : Google Scholar : PubMed/NCBI
25	Yang CM, Lee IT, Chi PL, Cheng SE, Hsiao LD and Hsu CK: TNF-α induces cytosolic phospholipase A2 expression via Jak2/PDGFR-dependent Elk-1/p300 activation in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 306:L543–L551. 2014. View Article : Google Scholar : PubMed/NCBI
26	Park GY and Christman JW: Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol. 290:L797–L805. 2006. View Article : Google Scholar : PubMed/NCBI
27	Yoshikawa S, Miyahara T, Reynolds SD, Stripp BR, Anghelescu M, Eyal FG and Parker JC: Clara cell secretory protein and phospholipase A2 activity modulate acute ventilator-induced lung injury in mice. J Appl Physiol (1985). 98:1264–1271. 2005. View Article : Google Scholar : PubMed/NCBI
28	Watanabe K, Iwahara C, Nakayama H, Iwabuchi K, Matsukawa T, Yokoyama K, Yamaguchi K, Kamiyama Y and Inada E: Sevoflurane suppresses tumour necrosis factor-α-induced inflammatory responses in small airway epithelial cells after anoxia/reoxygenation. Br J Anaesth. 110:637–645. 2013. View Article : Google Scholar : PubMed/NCBI
29	Song SY, Zhou B, Yang SM, Liu GZ, Tian JM and Yue XQ: Preventive effects of sevoflurane treatment on lung inflammation in rats. Asian Pac J Trop Med. 6:53–56. 2013. View Article : Google Scholar : PubMed/NCBI
30	Shen QY, Fang L, Wu HM, He F, Ding PS and Liu RY: Repeated inhalation of sevoflurane inhibits airway inflammation in an OVA-induced mouse model of allergic airway inflammation. Respirology. 20:258–263. 2015. View Article : Google Scholar : PubMed/NCBI
31	Matchett GA, Allard MW, Martin RD and Zhang JH: Neuroprotective effect of volatile anesthetic agents: Molecular mechanisms. Neurol Res. 31:128–134. 2009. View Article : Google Scholar : PubMed/NCBI
32	Rodríguez-González R, Baluja A, Del Río Veiras S, Rodríguez A, Rodríguez J, Taboada M, Brea D and Álvarez J: Effects of sevoflurane postconditioning on cell death, inflammation and TLR expression in human endothelial cells exposed to LPS. J Transl Med. 11:872013. View Article : Google Scholar : PubMed/NCBI